releases: https://zeldin.house.gov/media-center/press-releases/rep-zeldin-supports-legislation-lower-drug-prices
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://zeldin.house.gov/media-center/press-releases/rep-zeldin-supports-legislation-lower-drug-prices | Rep. Zeldin Supports Legislation to Lower Drug Prices | 2019-12-11 | 2019 | 2019-12 | Republican | House | NY | Lee Zeldin | Z000017 | zeldin.house.gov | legacy | WASHINGTON - Today, Congressman Lee Zeldin (R, NY-1) issued the following statement after cosponsoring the Lower Costs, More Cures Act (H.R. 19): The rising cost of prescription drugs has dealt a crushing blow to the wallets of everyday Americans and put a great strain on the government supported programs some of our country's most vulnerable populations - our seniors, children, disabled and impoverished communities - rely on. The American people demand bipartisan, commonsense action to lower the cost of prescription drugs, and I'm proud to support this legislation that would deliver for them and their families. The legislation packaged in the Lower Costs, More Cures Act is comprehensive and widely bipartisan, full of real solutions rather than partisan politics. I urge House Democratic leadership to bring this legislation, which would undoubtedly pass with wide bipartisan support, to a vote immediately. The Lower Costs, More Cures Act: Lowers the cost of prescription drugs by promoting more low-cost options for patients and curbing the gaming of the system by drug companies, all while encouraging innovation of groundbreaking new cures; For the first time ever, places a cap on seniors' out-of-pocket drug costs and allows seniors to manage their annual out-of-pocket spending; Makes insulin more affordable; Increases transparency and removes uncertainty at the pharmacy counter; Cuts the cost of drug administration, including cancer treatment for Medicare beneficiaries by as much as half; Stops subsidizing other developing countries' health care through stronger trade agreements with real enforcement mechanisms. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |